Guardant Health AMEA Wins Frost Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa
- Written by PR Newswire Asia - News Pronto RSS
MUMBAI, India, Dec. 15, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company's flagship liquid biopsy, the Guardant360® test, which oncologists are...